Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 17 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1747卷 / 1期

关键词：

D O I：

10.1007/s40278-019-59803-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：162 / 162

相关论文

共 50 条

[1] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 17 case reports
Reactions Weekly, 2018, 1724 (1) : 213 - 213
[2] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 17 case reports
Reactions Weekly, 2018, 1731 (1) : 150 - 150
[3] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1685 (1) : 117 - 117
[4] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2021, 1864 (1) : 203 - 203
[5] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 8 case reports
Reactions Weekly, 2020, 1791 (1) : 153 - 153
[6] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2021, 1849 (1) : 252 - 252
[7] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 2 case reports
Reactions Weekly, 2023, 1960 (1) : 248 - 248
[8] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 10 case reports
Reactions Weekly, 2021, 1840 (1) : 227 - 227
[9] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 38 case reports
Reactions Weekly, 2019, 1734 (1) : 295 - 295
[10] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 2 case reports
Reactions Weekly, 2018, 1715 (1) : 147 - 147

← 1 2 3 4 5 →